Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 228 (RN7SKP228) is a non-functional genomic sequence resembling the RN7SK small nuclear RNA gene. As a pseudogene, RN7SKP228 does not encode a functional RNA or protein product, and there is no evidence of biological activity, disease association, or function as a therapeutic target[4][6]. It is distinct from the functional RN7SK gene, which plays important roles in transcription regulation, but RN7SKP228 is not known to have any such function. RN7SKP228 should not be considered a druggable or biologically meaningful molecular target. The only substantive role of this entry is as a nonfunctional genomic relative of RN7SK, a small nuclear RNA involved in the regulation of transcriptional elongation by RNA polymerase II[1][5]. If you are seeking actionable or functional information, RN7SK itself (not the RN7SK pseudogenes) is the relevant molecule of biological interest[1][5]. There are no known drugs, mechanisms of action, or disease links for RN7SKP228[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 228 (RN7SKP228).